• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Suez Canal University Medical Journal
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 23 (2020)
Volume Volume 22 (2019)
Volume Volume 21 (2018)
Volume Volume 20 (2017)
Volume Volume 19 (2016)
Issue Issue 2
Issue Issue 1
Volume Volume 18 (2015)
Volume Volume 17 (2014)
Volume Volume 16 (2013)
Volume Volume 15 (2012)
Volume Volume 14 (2011)
Volume Volume 13 (2010)
Saleh, R. (2016). Natural Killer Cells in Hepatitis C Virus Infection. Suez Canal University Medical Journal, 19(2), 107-116. doi: 10.21608/scumj.2019.44163
Rania M Saleh. "Natural Killer Cells in Hepatitis C Virus Infection". Suez Canal University Medical Journal, 19, 2, 2016, 107-116. doi: 10.21608/scumj.2019.44163
Saleh, R. (2016). 'Natural Killer Cells in Hepatitis C Virus Infection', Suez Canal University Medical Journal, 19(2), pp. 107-116. doi: 10.21608/scumj.2019.44163
Saleh, R. Natural Killer Cells in Hepatitis C Virus Infection. Suez Canal University Medical Journal, 2016; 19(2): 107-116. doi: 10.21608/scumj.2019.44163

Natural Killer Cells in Hepatitis C Virus Infection

Editorial, Volume 19, Issue 2, October 2016, Page 107-116  XML PDF (633.1 K)
DOI: 10.21608/scumj.2019.44163
Author
Rania M Saleh email
Department of Clinical Pathology, Faculty of Medicine, Suez Canal University, Egypt
Abstract
Natural Killer (NK) cells account for the majority of innate immune cells in the human liver (the primary site of HCV replication). CD3–CD56+ NK cells are significantly increased in the liver compared to the peripheral blood although this becomes especially evident in chronic HCV infection. NK cells have been implicated in all stages of HCV infection in both genetic and functional studies. This role may be either direct, by targeting infected hepatocytes, or indirect by influencing other key immunocytes such as dendritic cells (DCs) or T cells. Hepatotropic viruses such as HCV induce production of type I Interferon (IFN) by hepatocytes and other cells in the liver, which in turn promotes infiltration of NK cells in virus infected livers. Production of type I IFN and other cytokines (including Interleukin (IL)-12, IL-15, and IL-18) by hepatocytes activates NK cells and induces IFN-γ production by them, which recruits activated T cells to the liver. It has been shown in animal models that depletion of NK cells before hepatotropic viral infection leads to inhibition of a virus-specific T cell response, as well as inhibition of liver injury.  It is possible that an adequate NK cell response may control HCV infection, even in the absence of virus-specific immune responses. NK cells have direct antiviral effects which are mediated by direct cytolytic (e.g., TRAIL or perforin mediated) or non-cytolytic (e.g., IFN-γ mediated) effector functions. Understanding the mechanisms by which HCV is successfully eradicated is especially important for therapeutic and vaccination strategies.
 
Keywords
apoptosis; interferon; Interleukins
Statistics
Article View: 89
PDF Download: 177
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.